BIOTECH GROWTH N V - 14 Jul 2022 Form 4 Insider Report for ESSA Pharma Inc. (EPIX)

Role: 10%+ Owner
Signature: /s/ Martin Gubler
Issuer symbol: EPIX
Transactions as of: 14 Jul 2022
Net transactions value: +$1,726,226
Form type: 4
Filing time: 18 Jul 2022, 12:48:05 UTC
Previous filing: 29 Apr 2022
Next filing: 20 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EPIX	Common Shares	Purchase	$969,428	+347,204	+7%	$2.79	5,337,918	14 Jul 2022	Direct
transaction	EPIX	Common Shares	Purchase	$756,798	+241,665	+4.5%	$3.13	5,579,583	15 Jul 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of ESSA Pharma Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V.